First Eagle Investment Management, LLC - ANTARES PHARMA INC ownership

ANTARES PHARMA INC's ticker is ATRS and the CUSIP is 036642106. A total of 84 filers reported holding ANTARES PHARMA INC in Q4 2013. The put-call ratio across all filers is 0.62 and the average weighting 0.1%.

Quarter-by-quarter ownership
First Eagle Investment Management, LLC ownership history of ANTARES PHARMA INC
ValueSharesWeighting
Q4 2017$100,000
-38.3%
50,0000.0%0.00%
Q3 2017$162,000
+153.1%
50,000
+150.0%
0.00%
Q2 2017$64,000
+12.3%
20,0000.0%0.00%
Q1 2017$57,000
+21.3%
20,0000.0%0.00%
Q4 2016$47,000
+38.2%
20,0000.0%0.00%
Q3 2016$34,000
+61.9%
20,0000.0%0.00%
Q2 2016$21,000
+23.5%
20,0000.0%0.00%
Q1 2016$17,000
-29.2%
20,0000.0%0.00%
Q4 2015$24,000
-29.4%
20,0000.0%0.00%
Q3 2015$34,000
-19.0%
20,0000.0%0.00%
Q2 2015$42,000
-22.2%
20,0000.0%0.00%
Q1 2015$54,000
+5.9%
20,0000.0%0.00%
Q4 2014$51,000
+37.8%
20,0000.0%0.00%
Q3 2014$37,000
-30.2%
20,0000.0%0.00%
Q2 2014$53,000
-24.3%
20,0000.0%0.00%
Q1 2014$70,000
-22.2%
20,0000.0%0.00%
Q4 2013$90,000
+11.1%
20,0000.0%0.00%
Q3 2013$81,000
-2.4%
20,0000.0%0.00%
Q2 2013$83,00020,0000.00%
Other shareholders
ANTARES PHARMA INC shareholders Q4 2013
NameSharesValueWeighting ↓
Stonepine Capital Management, LLC 3,130,192$12,834,0005.32%
Velan Capital Investment Management LP 1,346,971$5,523,0005.12%
FIRST WILSHIRE SECURITIES MANAGEMENT INC 2,799,953$11,480,0004.03%
Sargent Investment Group, LLC 3,663,275$15,019,0003.78%
PERKINS CAPITAL MANAGEMENT INC 481,483$1,974,0001.62%
Rubric Capital Management LP 10,900,000$44,690,0001.62%
ORACLE INVESTMENT MANAGEMENT INC 1,720,000$7,052,0001.39%
Long Focus Capital Management, LLC 540,000$2,214,0000.28%
OBERWEIS ASSET MANAGEMENT INC/ 344,200$1,411,0000.28%
FIRETHORN WEALTH PARTNERS, LLC 84,069$345,0000.26%
View complete list of ANTARES PHARMA INC shareholders